Colorectal and gastric cancer in 2015: The development of new agents and molecular classifications

Eric Van Cutsem; Michel Ducreux

doi:10.1038/nrclinonc.2015.217

Colorectal and gastric cancer in 2015: The development of new agents and molecular classifications

Eric Van Cutsem, Michel Ducreux

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

25 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	69-70
Nombre de pages	2
journal	Nature Reviews Clinical Oncology
Volume	13
Numéro de publication	2
Les DOIs	https://doi.org/10.1038/nrclinonc.2015.217
état	Publié - 1 févr. 2016

Accès au document

10.1038/nrclinonc.2015.217

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{83577bd867e7473c81b57bde96c2b8d6,

title = "Colorectal and gastric cancer in 2015: The development of new agents and molecular classifications",

author = "{Van Cutsem}, Eric and Michel Ducreux",

note = "Funding Information: E.V.C. has received research grants from Amgen, Bayer, Boehringer, Celgene, Ipsen, Lilly, Merck Serono, Novartis, Roche, and Sanofi. M.D. is on the advisory board and has attended symposia for Amgen, Celgene, Lilly, Merck, Novartis, and Roche. M.D.{\textquoteright}s wife is employed by Sandoz (Novartis group).",

year = "2016",

month = feb,

day = "1",

doi = "10.1038/nrclinonc.2015.217",

language = "English",

volume = "13",

pages = "69--70",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

number = "2",

}

TY - JOUR

T1 - Colorectal and gastric cancer in 2015

T2 - The development of new agents and molecular classifications

AU - Van Cutsem, Eric

AU - Ducreux, Michel

N1 - Funding Information: E.V.C. has received research grants from Amgen, Bayer, Boehringer, Celgene, Ipsen, Lilly, Merck Serono, Novartis, Roche, and Sanofi. M.D. is on the advisory board and has attended symposia for Amgen, Celgene, Lilly, Merck, Novartis, and Roche. M.D.’s wife is employed by Sandoz (Novartis group).

PY - 2016/2/1

Y1 - 2016/2/1

UR - http://www.scopus.com/inward/record.url?scp=84955671210&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2015.217

DO - 10.1038/nrclinonc.2015.217

M3 - Review article

C2 - 26667973

AN - SCOPUS:84955671210

SN - 1759-4774

VL - 13

SP - 69

EP - 70

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 2

ER -